Lv1
50 积分 2025-02-21 加入
A Circulating GPNMB-Based Multimodal Model Integrates Tumor-Immune Crosstalk to Predict Immunotherapy Response in Esophageal Cancer
17天前
已完结
GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors
17天前
已完结
Cancer immune evasion, immunoediting and intratumour heterogeneity
1个月前
已完结
Metabolites as signalling molecules in the tumour immune microenvironment
1个月前
已完结
CRISPR-Based Therapy for Hereditary Angioedema
1个月前
已完结
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trial
1个月前
已完结
Allogeneic CD19-targeted CAR-T therapy in refractory systemic lupus erythematosus achieved durable remission
1个月前
已完结
Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3
1个月前
已完结
An improved method to produce clinical scale natural killer cells from human pluripotent stem cells
7个月前
已完结
A chimeric peptide promotes immune surveillance of senescent cells in injury, fibrosis, tumorigenesis and aging
8个月前
已完结
皖公网安备34019202002308
